Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: Single-center, 14-year experience

Gastrointestinal Endoscopy

Volumn 74, Issue 2, 2011, Pages 295-302

  Pannala, Rahul ^a   Brandabur, John J ^a   Gan, Seng Ian ^a   Gluck, Michael ^a   Irani, Shayan ^a   Patterson, David J ^a   Ross, Andrew S ^a   Dorer, Russell ^a   Traverso, L William ^a   Picozzi, Vincent J ^a   Kozarek, Richard A ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DOCETAXEL; FLUOROURACIL; GEMCITABINE;

AFFERENT LOOP SYNDROME; ARTICLE; BALLOON DILATATION; BILIARY TRACT DRAINAGE; CANCER ADJUVANT THERAPY; CANCER CHEMORADIOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHOLANGITIS; CONTINUOUS INFUSION; ENDOSCOPIC THERAPY; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; JEJUNUM ULCER; LIVER ABSCESS; PANCREAS CANCER; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION ENTEROPATHY;

ADENOCARCINOMA; ADULT; AFFERENT LOOP SYNDROME; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; BALLOON DILATION; CHEMORADIOTHERAPY, ADJUVANT; CONSTRICTION, PATHOLOGIC; DRAINAGE; FEMALE; HUMANS; INTESTINES; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RADIATION INJURIES; RETROSPECTIVE STUDIES; STENTS; TIME FACTORS; ULCER;

EID: 79960942214     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2011.04.029     Document Type: Article

References (11)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Corsini MM, Miller RC, Haddock MG, et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol 2008;26:3511-6.
3. Hsu CC, Herman JM, Corsini MM, et al. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Ann Surg Oncol 2010;17:981-90.
4. Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 2008;247:456-62.
5. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2003;185:476-80. (Pubitemid 36513960)
6. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006;10:1199-210; discussion 1210-1.
7. Jacobs NL, Que FG, Miller RC, et al. Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer. J Gastrointest Cancer 2009;40:46-50.
8. Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am 1992;72:445-65.
9. Aimoto T, Uchida E, Nakamura Y, et al. Malignant afferent loop obstruction following pancreaticoduodenectomy: report of two cases. J Nippon Med Sch 2006;73:226-30. (Pubitemid 44274098)
10. Caldicott DG, Ziprin P, Morgan R. Transhepatic insertion of a metallic stent for the relief of malignant afferent loop obstruction. Cardiovasc Intervent Radiol 2000;23:138-40. (Pubitemid 30220587)
11. Chevallier P, Novellas S, Motamedi JP, et al. Percutaneous jejunostomy and stent placement for treatment of malignant Roux-en-Y obstruction: a case report. Clin Imaging 2006;30:283-6. (Pubitemid 43928535)